Home/Filings/3/0001213900-21-009809
3//SEC Filing

Virpax Pharmaceuticals LLC 3

Accession 0001213900-21-009809

CIK 0001708331other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 7:16 PM ET

Size

11.3 KB

Accession

0001213900-21-009809

Insider Transaction Report

Form 3
Period: 2021-02-16
Holdings
  • Common Stock, $0.00001 par value per share

    2,730,438

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001842247

Filing Metadata

Form type
3
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:16 PM ET
Size
11.3 KB